← All institutions

Goldman Sachs

365 reports

Reports from this institution

Goldman Sachs

Goldman Sachs: Weichai Power: Goldman Sachs expects data-center power generation to contribute about half of net profit in 2027

Goldman Sachs sees data-center power generation as a new profit engine for Weichai: gas-fired generator sets will drive near-term growth, while fuel cells will scale up from 2028. Its target price also incorporates earnings from the primary power-supply business in 2030, making the pace at which growth materializes a direct influence on valuation.

Goldman Sachs

Goldman Sachs: Amkor's advanced packaging growth fails to offset end-market weakness; Goldman Sachs cuts price target

The computing business continues to benefit from the ramp-up of 2.5D packaging and CPU programs, but third-quarter margins and fourth-quarter revenue and EPS guidance all fell short of market expectations. Goldman Sachs maintained its Neutral rating and cut its price target from $ '65' to $ '56', focusing on whether capacity expansion can deliver stronger earnings and cash flow.

Goldman Sachs

Goldman Sachs: Apple earnings preview: Price increases support revenue, but why is Goldman Sachs raising its target price as profits face pressure?

Goldman Sachs expects Apple’s revenue for the September quarter to be broadly in line with consensus, with iPhone growth driven mainly by price increases and a higher share of premium models; its profit expectations for the December quarter, however, are below consensus. The target price rises to 390 dollars, mainly reflecting greater confidence that Duo will drive upgrades, rather than higher earnings forecasts.

Goldman Sachs

Goldman Sachs: Sieyuan Electric: Operating profit meets Goldman Sachs expectations, while overseas orders still take time to translate into revenue

Third-quarter revenue rose 31% and operating profit grew 30%, but net profit increased only 5%. Goldman Sachs believes operations remain resilient; the key factors are the timing of acceptance and delivery, a rising share of low-margin businesses, and whether North American orders can continue to translate into revenue amid policy uncertainty.

Goldman Sachs

Goldman Sachs: Risk appetite falls below zero as tech stocks drive cross-asset moves; positioning remains moderately bullish

Goldman Sachs’ risk appetite indicator has fallen to its lowest level since April 2025, but remains some way from historical contrarian signals. Technology stocks have become an important driver of cross-asset volatility. The bank continues to overweight equities, balanced by an underweight in credit, a short-term overweight in cash and a long-term overweight in bonds.

Goldman Sachs

Goldman Sachs: KOA raises full-year guidance again: Why is Goldman Sachs optimistic about Japanese passive-component earnings?

KOA’s second-quarter operating profit rose to about 2.6 times its level a year earlier, as sales growth, capacity utilization and product mix improved together. Goldman Sachs sees this as a reason to be optimistic about the earnings momentum of Japanese passive-component companies, but most of the increase in orders came from orders placed early, and there is also a lag in passing on higher material costs.

Goldman Sachs

Goldman Sachs: Lepu Medical’s third quarter falls short of Goldman Sachs’ expectations: Core business stabilizes gradually as R&D spending weighs on profit recovery

Lepu Medical’s third-quarter revenue and net profit fell 10% and 39% year on year, respectively. The devices business showed signs of stabilization, but price adjustments for pharmaceutical preparations continued to depress revenue, while investment in innovative drugs continued to consume profits. Goldman Sachs cut its target price from 15 yuan to 14 yuan and maintained its Neutral rating.

Goldman Sachs

Goldman Sachs: Hisense Home Appliances’ third-quarter profit falls 74% as domestic demand, copper prices and promotions squeeze earnings

Hisense Home Appliances’ revenue for the third quarter of 2026 was just 4% below Goldman Sachs’ forecast, but net profit was 67% lower. The air-conditioning business faced weak demand, rising copper prices and pressure to cut prices; growth overseas and in refrigerators and washing machines provided support but failed to offset the decline in earnings. Goldman Sachs maintained its Buy rating, with its long-term thesis still dependent on growth in multi-split air-conditioning systems and improved operating efficiency.

Goldman Sachs

Goldman Sachs: Moderna’s cancer vaccine meets Phase III endpoint: why does Goldman Sachs favor expansion into kidney cancer while maintaining a Neutral rating?

Intismeran combined with Keytruda significantly improved recurrence-free survival after melanoma surgery, while early pancreatic cancer data provide mechanistic support for expansion into kidney cancer. But the wait for treatment to take effect, tissue sample requirements for manufacturing, and immature overall survival data still constrain the realization of the platform’s value.